AnalytixInsight Partners with Samsung and the London Stock Exchange Group

AnalytixInsight Partners with Samsung and the London Stock Exchange Group

By: Dylan Sikes - AllPennyStocks.com News

Tuesday, January 14, 2014

Today’s investing climate is far different from past decades, with investors having access to more data than ever before to make informed decisions and be more proactive about controlling a portfolio on their own. To a certain extent, it can be a bit of a double-edged sword with so much information available that discerning which sources are credible to use can be confusing to novices and the number of hours sifting through data while performing due diligence can really stack up. Still, though, to self-motivated traders, it beats the alternative. There are many interesting companies out there that offer valuable platforms, but limited marketing sometimes keeps them from being in plain view. Vancouver, British Columbia-based data and analytics company AnalytixInsight Inc. (TSX-Venture:ALY) seems to fit that mold, but the company could be coming to a small screen near you in the close future.


Through its online portal CapitalCube.com, the company offers financial research and content for investors, financial portals, media and information providers. The website, which launched last year, has both free and subscription components. AnalytixInsight algorithms analyze market price, charts, fundamentals, etc. to create comparisons between companies and peers to provide unique insight on about 45,000 public companies traded around the world and serves it up as a cloud-based, Software-as-a-Service platform. Financial websites have chimed-in with positive commentary, including Barron’s saying “There’s nothing quite like it” and Globes calling it “the hottest financial site to select stocks.”

The company said on Tuesday that it has teamed with Proquote – the information services arm of London Stock Exchange Group – and Samsung Electronics Italia S.p.A., a division of Samsung Electronics Co. The initial thrust of the collaboration is to integrate real-time stock quotes supplied by Proquote with the company research and analysis of CapitalCube, which will be delivered through Samsung’s Smart TVs and mobile devices. The goal is to provide a robust data set for companies listed on various global exchanges, without the need for any additional hardware while meeting the demands of today’s mobile world.

The launch of the new platform is expected at the end of the first quarter this year, with an ongoing rollout covering major markets in Europe, North America and Asia.

"AnalytixInsight's unique platform allows us to process structured data to rapidly create narratives with analysis and insights," said Prakash Hariharan, chairman of AnalytixInsight, in a statement today. "Samsung's innovative products are an engaging part of the lives of people in nearly 80 countries. By teaming up with the global leader in consumer electronics, we are putting the power of Big Data and Analytics into the hands of millions of people around the world."

Shares of ALY aren’t responding positively to the news in Tuesday trading action, slipping down by 9 percent to 80 cents as the day winds to a close. This does not insinuate that investors haven’t been bullish on the company, as the stock has risen from lows of 5 cents last April to print a 52-week high of 96 cents last week. With a market cap of only $21 million, there seems plenty of headroom for growth from these levels. Proper due diligence is, as always, encouraged.

Copyright © 2014 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Miner Scores with Acquisition of Promising Silver District in Mexico
Mixed Signals: Durable Goods Orders Up, But Not All Sectors Are Soaring
Biotech Steals The Show Following Pre-Clinical Data Announcement
Most Popular
FREE Newsletter


Back to Top